Gilad Shabtai is 10% Owner at Eloxx Pharmaceuticals, Inc. (ELOX). They have made 3 open-market trades across 1 company since 2018, most recently 2018-04-30.
CIK 0001726027
3 open-market purchases totalling $853K since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ELOX | 3,351,770 | $43.2M |
Shares reported on the most recent Form 4, priced at the 2018-05-01 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.